Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives
March 22, 2022 16:06 ET
|
Exagen Inc.
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests will soon surpass 90 million lives as...
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection
January 09, 2022 12:00 ET
|
Exagen Inc.
SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a...
Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 17, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Piper Sandler 33rd Annual Virtual...
Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021
October 21, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today it will be presenting new scientific research at the...
Exagen Inc. Reports Second Quarter 2020 Results
July 28, 2020 07:00 ET
|
Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
July 27, 2020 16:05 ET
|
Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen Inc. Reports Third Quarter 2019 Results
November 12, 2019 16:05 ET
|
Exagen, Inc.
AVISE® Testing Revenue Drives 27% Revenue Growth SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients...
Improved Laboratory Testing with EC4d Can Help Physicians Monitor Patients with Lupus
June 12, 2017 07:43 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, June 12, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc., home of AVISE® testing, announced the nationwide availability of a new test leveraging the power of...